Greater Occipital Nerve Blockade for Cluster Headache

Cluster headache is perhaps the most painful of the primary headache disorders. Its treatment includes acute, transitional, and preventive therapy. Despite the availability of many treatments, cluster headache patients can still be difficult to treat. We treated 14 cluster headache patients with gre...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cephalalgia 2002-09, Vol.22 (7), p.520-522
Hauptverfasser: Peres, MFP, Stiles, MA, Siow, HC, Rozen, TD, Young, WB, Silberstein, SD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 522
container_issue 7
container_start_page 520
container_title Cephalalgia
container_volume 22
creator Peres, MFP
Stiles, MA
Siow, HC
Rozen, TD
Young, WB
Silberstein, SD
description Cluster headache is perhaps the most painful of the primary headache disorders. Its treatment includes acute, transitional, and preventive therapy. Despite the availability of many treatments, cluster headache patients can still be difficult to treat. We treated 14 cluster headache patients with greater occipital nerve block as transitional therapy (treatment initiated at the same time as preventive therapy). The mean number of headache-free days was 13.1+23.6. Four patients (28.5%) had a good response, five (35.7%) a moderate, and five (35.7%) no response. The greater occipital nerve block was well tolerated with no adverse events. Headache intensity, frequency and duration were significantly decreased comparing the week before with the week after the nerve block (P< 0.003, P = 0.003, P< 0.005, respectively). Greater occipital nerve blockade is a therapeutic option for the transitional treatment of cluster headache.
doi_str_mv 10.1046/j.1468-2982.2002.00410.x
format Article
fullrecord <record><control><sourceid>proquest_AFRWT</sourceid><recordid>TN_cdi_proquest_miscellaneous_72098053</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1046_j.1468-2982.2002.00410.x</sage_id><sourcerecordid>72098053</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4860-a317b819c4d4f6dfdbfeada49c728af299d43a1af0158328d9e618696799db723</originalsourceid><addsrcrecordid>eNqNkDtPwzAYRS0EouXxF1AmtoTPjzj2wABRaZEqygCz5TgOJKRNsRto_z0JqWCEyZbuudfWQSjAEGFg_KqKMOMiJFKQiACQCIB12fYAjX-CQzQGSmmIgbAROvG-AoCYAz9GI0wIhVjSMYqnzuqNdcHCmHJdbnQdPFj3YYPbujFvOrdB0bggrVvfQzOrc21e7Rk6KnTt7fn-PEXPd5OndBbOF9P79GYeGiY4hJriJBNYGpazgudFnhX9AJMmIUIXRMqcUY11ATgWlIhcWo4Flzzpkiwh9BRdDrtr17y31m_UsvTG1rVe2ab1KiEgBcS0A8UAGtd472yh1q5cardTGFSvTFWqN6N6M6pXpr6VqW1Xvdi_0WZLm_8W94464HoAPsva7v49rNLJ46y7df146Hv9YlXVtG7VOfv7Y18DQYid</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72098053</pqid></control><display><type>article</type><title>Greater Occipital Nerve Blockade for Cluster Headache</title><source>Sage Journals GOLD Open Access 2024</source><creator>Peres, MFP ; Stiles, MA ; Siow, HC ; Rozen, TD ; Young, WB ; Silberstein, SD</creator><creatorcontrib>Peres, MFP ; Stiles, MA ; Siow, HC ; Rozen, TD ; Young, WB ; Silberstein, SD</creatorcontrib><description>Cluster headache is perhaps the most painful of the primary headache disorders. Its treatment includes acute, transitional, and preventive therapy. Despite the availability of many treatments, cluster headache patients can still be difficult to treat. We treated 14 cluster headache patients with greater occipital nerve block as transitional therapy (treatment initiated at the same time as preventive therapy). The mean number of headache-free days was 13.1+23.6. Four patients (28.5%) had a good response, five (35.7%) a moderate, and five (35.7%) no response. The greater occipital nerve block was well tolerated with no adverse events. Headache intensity, frequency and duration were significantly decreased comparing the week before with the week after the nerve block (P&lt; 0.003, P = 0.003, P&lt; 0.005, respectively). Greater occipital nerve blockade is a therapeutic option for the transitional treatment of cluster headache.</description><identifier>ISSN: 0333-1024</identifier><identifier>EISSN: 1468-2982</identifier><identifier>DOI: 10.1046/j.1468-2982.2002.00410.x</identifier><identifier>PMID: 12230593</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><subject>Adult ; Aged ; Cluster headache ; Cluster Headache - drug therapy ; Cluster Headache - physiopathology ; Cluster Headache - therapy ; Female ; Humans ; Lidocaine - pharmacology ; Lidocaine - therapeutic use ; Male ; Middle Aged ; nerve block ; Nerve Block - methods ; Occipital Lobe - drug effects ; Occipital Lobe - physiology ; occipital nerve ; Statistics, Nonparametric ; Triamcinolone - pharmacology ; Triamcinolone - therapeutic use</subject><ispartof>Cephalalgia, 2002-09, Vol.22 (7), p.520-522</ispartof><rights>2002 International Headache Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4860-a317b819c4d4f6dfdbfeada49c728af299d43a1af0158328d9e618696799db723</citedby><cites>FETCH-LOGICAL-c4860-a317b819c4d4f6dfdbfeada49c728af299d43a1af0158328d9e618696799db723</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1046/j.1468-2982.2002.00410.x$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1046/j.1468-2982.2002.00410.x$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,776,780,1411,21798,21945,27830,27901,27902,43597,43598,44921,45309,45550,45551</link.rule.ids><linktorsrc>$$Uhttps://journals.sagepub.com/doi/full/10.1046/j.1468-2982.2002.00410.x?utm_source=summon&amp;utm_medium=discovery-provider$$EView_record_in_SAGE_Publications$$FView_record_in_$$GSAGE_Publications</linktorsrc><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12230593$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Peres, MFP</creatorcontrib><creatorcontrib>Stiles, MA</creatorcontrib><creatorcontrib>Siow, HC</creatorcontrib><creatorcontrib>Rozen, TD</creatorcontrib><creatorcontrib>Young, WB</creatorcontrib><creatorcontrib>Silberstein, SD</creatorcontrib><title>Greater Occipital Nerve Blockade for Cluster Headache</title><title>Cephalalgia</title><addtitle>Cephalalgia</addtitle><description>Cluster headache is perhaps the most painful of the primary headache disorders. Its treatment includes acute, transitional, and preventive therapy. Despite the availability of many treatments, cluster headache patients can still be difficult to treat. We treated 14 cluster headache patients with greater occipital nerve block as transitional therapy (treatment initiated at the same time as preventive therapy). The mean number of headache-free days was 13.1+23.6. Four patients (28.5%) had a good response, five (35.7%) a moderate, and five (35.7%) no response. The greater occipital nerve block was well tolerated with no adverse events. Headache intensity, frequency and duration were significantly decreased comparing the week before with the week after the nerve block (P&lt; 0.003, P = 0.003, P&lt; 0.005, respectively). Greater occipital nerve blockade is a therapeutic option for the transitional treatment of cluster headache.</description><subject>Adult</subject><subject>Aged</subject><subject>Cluster headache</subject><subject>Cluster Headache - drug therapy</subject><subject>Cluster Headache - physiopathology</subject><subject>Cluster Headache - therapy</subject><subject>Female</subject><subject>Humans</subject><subject>Lidocaine - pharmacology</subject><subject>Lidocaine - therapeutic use</subject><subject>Male</subject><subject>Middle Aged</subject><subject>nerve block</subject><subject>Nerve Block - methods</subject><subject>Occipital Lobe - drug effects</subject><subject>Occipital Lobe - physiology</subject><subject>occipital nerve</subject><subject>Statistics, Nonparametric</subject><subject>Triamcinolone - pharmacology</subject><subject>Triamcinolone - therapeutic use</subject><issn>0333-1024</issn><issn>1468-2982</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkDtPwzAYRS0EouXxF1AmtoTPjzj2wABRaZEqygCz5TgOJKRNsRto_z0JqWCEyZbuudfWQSjAEGFg_KqKMOMiJFKQiACQCIB12fYAjX-CQzQGSmmIgbAROvG-AoCYAz9GI0wIhVjSMYqnzuqNdcHCmHJdbnQdPFj3YYPbujFvOrdB0bggrVvfQzOrc21e7Rk6KnTt7fn-PEXPd5OndBbOF9P79GYeGiY4hJriJBNYGpazgudFnhX9AJMmIUIXRMqcUY11ATgWlIhcWo4Flzzpkiwh9BRdDrtr17y31m_UsvTG1rVe2ab1KiEgBcS0A8UAGtd472yh1q5cardTGFSvTFWqN6N6M6pXpr6VqW1Xvdi_0WZLm_8W94464HoAPsva7v49rNLJ46y7df146Hv9YlXVtG7VOfv7Y18DQYid</recordid><startdate>200209</startdate><enddate>200209</enddate><creator>Peres, MFP</creator><creator>Stiles, MA</creator><creator>Siow, HC</creator><creator>Rozen, TD</creator><creator>Young, WB</creator><creator>Silberstein, SD</creator><general>SAGE Publications</general><general>Blackwell Science Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200209</creationdate><title>Greater Occipital Nerve Blockade for Cluster Headache</title><author>Peres, MFP ; Stiles, MA ; Siow, HC ; Rozen, TD ; Young, WB ; Silberstein, SD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4860-a317b819c4d4f6dfdbfeada49c728af299d43a1af0158328d9e618696799db723</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Cluster headache</topic><topic>Cluster Headache - drug therapy</topic><topic>Cluster Headache - physiopathology</topic><topic>Cluster Headache - therapy</topic><topic>Female</topic><topic>Humans</topic><topic>Lidocaine - pharmacology</topic><topic>Lidocaine - therapeutic use</topic><topic>Male</topic><topic>Middle Aged</topic><topic>nerve block</topic><topic>Nerve Block - methods</topic><topic>Occipital Lobe - drug effects</topic><topic>Occipital Lobe - physiology</topic><topic>occipital nerve</topic><topic>Statistics, Nonparametric</topic><topic>Triamcinolone - pharmacology</topic><topic>Triamcinolone - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Peres, MFP</creatorcontrib><creatorcontrib>Stiles, MA</creatorcontrib><creatorcontrib>Siow, HC</creatorcontrib><creatorcontrib>Rozen, TD</creatorcontrib><creatorcontrib>Young, WB</creatorcontrib><creatorcontrib>Silberstein, SD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cephalalgia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Peres, MFP</au><au>Stiles, MA</au><au>Siow, HC</au><au>Rozen, TD</au><au>Young, WB</au><au>Silberstein, SD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Greater Occipital Nerve Blockade for Cluster Headache</atitle><jtitle>Cephalalgia</jtitle><addtitle>Cephalalgia</addtitle><date>2002-09</date><risdate>2002</risdate><volume>22</volume><issue>7</issue><spage>520</spage><epage>522</epage><pages>520-522</pages><issn>0333-1024</issn><eissn>1468-2982</eissn><abstract>Cluster headache is perhaps the most painful of the primary headache disorders. Its treatment includes acute, transitional, and preventive therapy. Despite the availability of many treatments, cluster headache patients can still be difficult to treat. We treated 14 cluster headache patients with greater occipital nerve block as transitional therapy (treatment initiated at the same time as preventive therapy). The mean number of headache-free days was 13.1+23.6. Four patients (28.5%) had a good response, five (35.7%) a moderate, and five (35.7%) no response. The greater occipital nerve block was well tolerated with no adverse events. Headache intensity, frequency and duration were significantly decreased comparing the week before with the week after the nerve block (P&lt; 0.003, P = 0.003, P&lt; 0.005, respectively). Greater occipital nerve blockade is a therapeutic option for the transitional treatment of cluster headache.</abstract><cop>London, England</cop><pub>SAGE Publications</pub><pmid>12230593</pmid><doi>10.1046/j.1468-2982.2002.00410.x</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier ISSN: 0333-1024
ispartof Cephalalgia, 2002-09, Vol.22 (7), p.520-522
issn 0333-1024
1468-2982
language eng
recordid cdi_proquest_miscellaneous_72098053
source Sage Journals GOLD Open Access 2024
subjects Adult
Aged
Cluster headache
Cluster Headache - drug therapy
Cluster Headache - physiopathology
Cluster Headache - therapy
Female
Humans
Lidocaine - pharmacology
Lidocaine - therapeutic use
Male
Middle Aged
nerve block
Nerve Block - methods
Occipital Lobe - drug effects
Occipital Lobe - physiology
occipital nerve
Statistics, Nonparametric
Triamcinolone - pharmacology
Triamcinolone - therapeutic use
title Greater Occipital Nerve Blockade for Cluster Headache
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T04%3A23%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_AFRWT&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Greater%20Occipital%20Nerve%20Blockade%20for%20Cluster%20Headache&rft.jtitle=Cephalalgia&rft.au=Peres,%20MFP&rft.date=2002-09&rft.volume=22&rft.issue=7&rft.spage=520&rft.epage=522&rft.pages=520-522&rft.issn=0333-1024&rft.eissn=1468-2982&rft_id=info:doi/10.1046/j.1468-2982.2002.00410.x&rft_dat=%3Cproquest_AFRWT%3E72098053%3C/proquest_AFRWT%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72098053&rft_id=info:pmid/12230593&rft_sage_id=10.1046_j.1468-2982.2002.00410.x&rfr_iscdi=true